Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10020992HBVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS30068539HIVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS20011203HPVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS20046448HPVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS20023625HPVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS20066652HPVENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TVIS44035611HTLV-1ENSG00000003989.18protein_codingSLC7A2NoNo6542P52569
TCGA Plot Options
Drug Information
GeneSLC7A2
DrugBank IDDB00123
Drug NameLysine
Target IDBE0000562
UniProt IDP52569
Regulation Type
PubMed IDs17139284; 17016423; 7499219; 15746185; 12475743
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Low BC, Grigor MR: Angiotensin II stimulates system y+ and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells. J Biol Chem. 1995 Nov 17;270(46):27577-83.@@Rotoli BM, Bussolati O, Sala R, Gazzola GC, Dall'Asta V: The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors. FASEB J. 2005 May;19(7):810-2. Epub 2005 Mar 3.@@Schwartz D, Schwartz IF, Gnessin E, Wollman Y, Chernichovsky T, Blum M, Iaina A: Differential regulation of glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide-treated rats. Am J Physiol Renal Physiol. 2003 Apr;284(4):F788-95. Epub 2002 Dec 10.
GroupsApproved; Nutraceutical
Direct ClassificationL-alpha-amino acids
SMILESNCCCC[C@H](N)C(O)=O
PathwaysMultiple Carboxylase Deficiency, Neonatal or Early Onset Form; Biotin Metabolism; Glutaric Aciduria Type I; 2-Aminoadipic 2-Oxoadipic Aciduria; Hyperlysinemia II or Saccharopinuria; Hyperlysinemia I, Familial; Saccharopinuria/Hyperlysinemia II; Carnitine Synthesis; Lysine Degradation; Biotinidase Deficiency; Pyridoxine Dependency with Seizures
PharmGKBPA450280
ChEMBLCHEMBL8085